Press ReleaseAmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene TherapeuticsOctober 31, 2023
Press ReleaseVector BioMed's CEO, Dr. Boro Dropulić, to Speak at the 8th CAR-TCR SummitAugust 21, 2023
Press ReleaseVector BioMed Appoints Jakob Reiser, Ph.D., as Senior Director of Regulatory AffairsApril 11, 2023
Press ReleaseBiomanufacturing Company Vector BioMed Launches with Mission to Provide Access to High-Quality Lentiviral Vectors and Address the Vector Supply BottleneckJanuary 31, 2023